Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GCAR1 in Alveolar Soft Part Sarcoma
NCT06789081Phase 1Active, not recruiting
- Sponsor
- American Health Staffing Group
- Start
- Feb 2024
- Primary completion
- Mar 2028
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of GCAR1 in alveolar soft part sarcoma (ASPS), sponsored by American Health Staffing Group. Primary endpoint: Anti-tumor activity at 1 year. Started Feb 2024; status: active, not recruiting.
02
Drugs
GCAR1
03
Conditions
alveolar soft part sarcoma (ASPS)
Beyond the preview
Go deeper on NCT06789081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06789081.